A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

NCT ID: NCT01458574

Last Updated: 2017-05-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

593 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-20

Study Completion Date

2016-05-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis (UC). The study proposes to assess whether compared to placebo, CP-690,550 maintenance therapy more effectively achieves mucosal healing and improves quality of life in subjects with UC.The study proposes to assess CP-690,550 pharmacokinetic exposure during maintenance therapy in subjects over the age of 18 years with UC.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Comparator

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo 10 mg orally (PO) twice a day (BID)

CP-690,550 5 mg Arm

Group Type EXPERIMENTAL

CP690,550

Intervention Type DRUG

CP-690,550 5 mg orally (PO) twice a day (BID)

CP-690,550 10 mg Arm

Group Type EXPERIMENTAL

CP-690,550

Intervention Type DRUG

CP-690,550 10 mg orally (PO) twice a day (BID)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Placebo 10 mg orally (PO) twice a day (BID)

Intervention Type DRUG

CP690,550

CP-690,550 5 mg orally (PO) twice a day (BID)

Intervention Type DRUG

CP-690,550

CP-690,550 10 mg orally (PO) twice a day (BID)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who met study entry criteria and completed 8-week induction treatment from Study A3921094 or A3921095
* Subjects who achieved clinical response in Study A3921094 or A3921095
* Women of childbearing potential must test negative for pregnancy prior to study enrollment
* Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
* Evidence of a personally signed and dated informed consent document(s) indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.

Exclusion Criteria

* Subjects who had major protocol violation (as determined by the Sponsor) in Study A3921094 or A3921095
* Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease
* Subjects who have had surgery for UC or in the opinion of the investigator, are likely to require surgery for UC during the study period.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Internal Medicine Center, LLC

Mobile, Alabama, United States

Site Status

Springhill Memorial Hospital (Endoscopy Only)

Mobile, Alabama, United States

Site Status

UCSD Health System - Investigational Drug Pharmacy - Moores Cancer Center

La Jolla, California, United States

Site Status

UCSD Medical Center

La Jolla, California, United States

Site Status

Alliance Clinical Research

Oceanside, California, United States

Site Status

Desert Advanced Imaging

Palm Springs, California, United States

Site Status

Erik Palmer, DO

Palm Springs, California, United States

Site Status

Homan A Zadeh, MD, MPH

Palm Springs, California, United States

Site Status

Hope Square Surgical Center

Rancho Mirage, California, United States

Site Status

Sharp Rees-Stealy Medical Group, Inc.

San Diego, California, United States

Site Status

Clinical Applications Laboratories, Inc

San Diego, California, United States

Site Status

San Diego Endoscopy Center

San Diego, California, United States

Site Status

Sharp Rees-Stealy Medical Group

San Diego, California, United States

Site Status

UCSF Endoscopy Unit at Mount Zion

San Francisco, California, United States

Site Status

University of California San Francisco

San Francisco, California, United States

Site Status

Bristol Hospital

Bristol, Connecticut, United States

Site Status

Connecticut Clinical Research Foundation

Bristol, Connecticut, United States

Site Status

Endoscopy Center of Connecticut, LLC

Guilford, Connecticut, United States

Site Status

Endoscopy Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Gastroenterology Center of Connecticut, PC

Hamden, Connecticut, United States

Site Status

Medical Research Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Central Connecticut Endoscopy Center

Plainville, Connecticut, United States

Site Status

Citrus Surgery & Endoscopy Center (colonoscopy)

Crystal River, Florida, United States

Site Status

Nature Coast Clinical Research

Inverness, Florida, United States

Site Status

Suncoast Endoscopy Center (colonoscopy)

Inverness, Florida, United States

Site Status

North Florida Gastroenterology Research, LLC

Orange Park, Florida, United States

Site Status

Citrus Ambulatory Surgery Center

Orlando, Florida, United States

Site Status

Internal Medicine Specialists

Orlando, Florida, United States

Site Status

Advanced Gastroenterology Center

Port Orange, Florida, United States

Site Status

Advanced Medical Research Center

Port Orange, Florida, United States

Site Status

Endoscopy Center

Port Orange, Florida, United States

Site Status

Port Orange Urgent Care

Port Orange, Florida, United States

Site Status

Florida Medical Clinic, P.A.

Zephyhills, Florida, United States

Site Status

Florida Medical Clinic, P.A.

Zephyrhills, Florida, United States

Site Status

Georgia Endoscopy Center

Alpharetta, Georgia, United States

Site Status

GI Consultants

Atlanta, Georgia, United States

Site Status

Emory Healthcare Heart Center

Johns Creek, Georgia, United States

Site Status

Gastroenterology Associates of Central Georgia, LLC

Macon, Georgia, United States

Site Status

Atlanta Gastroenterology Specialists, PC

Suwanee, Georgia, United States

Site Status

Johns Creek Diagnostic Center

Suwanee, Georgia, United States

Site Status

Cotton-O'Neal Clinical Research Center Digestive Health

Topeka, Kansas, United States

Site Status

Digestive Disease Associates, PA

Baltimore, Maryland, United States

Site Status

Gastrointestinal Diagnostic Center

Baltimore, Maryland, United States

Site Status

Digestive Disease Associates, PA

Catonsville, Maryland, United States

Site Status

Howard County GIDC

Columbia, Maryland, United States

Site Status

Saint Joseph Mercy Hospital - Inpatient Pharmacy

Ann Arbor, Michigan, United States

Site Status

East Ann Arbor Health and Geriatrics Center - UMHS

Ann Arbor, Michigan, United States

Site Status

University of Michigan Health Systems

Ann Arbor, Michigan, United States

Site Status

Michigan Clinical Research Unit - UMHS

Ann Arbor, Michigan, United States

Site Status

Medical Science Research Building 1 - UMHS

Ann Arbor, Michigan, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Center for Digestive Health

Troy, Michigan, United States

Site Status

Surgical Centers of Michigan

Troy, Michigan, United States

Site Status

Utica Surgery Center (Endoscopy Only)

Utica, Michigan, United States

Site Status

Michigan Heart SJMH

Ypsilanti, Michigan, United States

Site Status

Huron Gastroenterology Associates

Ypsilanti, Michigan, United States

Site Status

Saint Joseph Mercy Hospital Outpatient Laboratory

Ypsilanti, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

AGA Clinical Research Associates, LLC

Egg Harbour Township, New Jersey, United States

Site Status

South Jersey Gastroenterology

Marlton, New Jersey, United States

Site Status

The Endo Center at Voorhees

Vorhees, New Jersey, United States

Site Status

NYU Langone Long Island Clinical Research Associates

Great Neck, New York, United States

Site Status

NYU Langone Nassau Gastroenterology Associates

Great Neck, New York, United States

Site Status

The Private Practice of Simon Lichtiger, MD

New York, New York, United States

Site Status

IBD Center - The Mount Sinai Hospital

New York, New York, United States

Site Status

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Site Status

Columbia University Medical Center

New York, New York, United States

Site Status

CUMC Research Pharmacy

New York, New York, United States

Site Status

Kornbluth, Legnani, George MD, PC

New York, New York, United States

Site Status

University of Rochester

Rochester, New York, United States

Site Status

Carolina Research, Carolina Digestive Diseases

Greenville, North Carolina, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Great Lakes Gastroenterology

Mentor, Ohio, United States

Site Status

Mentor Medical Campus

Mentor, Ohio, United States

Site Status

The Endoscopy Center of Lake County

Mentor, Ohio, United States

Site Status

Regional Gastroenterology Associates of Lancaster, Ltd.

Lancaster, Pennsylvania, United States

Site Status

Professional Quality Research, Inc.- Austin Gastroenterology PA

Austin, Texas, United States

Site Status

Austin Endoscopy Center II

Austin, Texas, United States

Site Status

Austin Gastroenterology PA

Austin, Texas, United States

Site Status

Houston Hospital for Specialized Surgery (Endoscopy only)

Houston, Texas, United States

Site Status

Baylor College of Medicine (Baylor Medical Center)

Houston, Texas, United States

Site Status

Baylor College of Medicine - Baylor Medical Center (Drug Storage)

Houston, Texas, United States

Site Status

McGovern Medical School -The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Memorial Hermann Hospital

Houston, Texas, United States

Site Status

Digestive Health Specialists of Tyler

Tyler, Texas, United States

Site Status

Alpine Medical Group

Salt Lake City, Utah, United States

Site Status

Wasatch Clinical Research

Salt Lake City, Utah, United States

Site Status

Wasatch Endoscopy Center

Salt Lake City, Utah, United States

Site Status

VCU Health System Digestive Health Center

Richmond, Virginia, United States

Site Status

VCU Health System Endoscopy Suite

Richmond, Virginia, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

The Center for Digestive Health

Milwaukee, Wisconsin, United States

Site Status

Wisconsin Center for Advanced Research

Milwaukee, Wisconsin, United States

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Liverpool Hospital

Liverpool, New South Wales, Australia

Site Status

Eastern Health-Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

Monash Medical Centre

Clayton, Victoria, Australia

Site Status

AKH Wien, Universitaetsklinik fuer Innere Medizin III

Vienna, Vienna, Austria

Site Status

GZA St. Vincentius

Antwerp, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

UZ Leuven (University Hospital Leuven), Campus Gasthuisberg

Leuven, , Belgium

Site Status

H-Hartziekenhuis Roeselare-Menen vzw

Roeselare, , Belgium

Site Status

Hospital de Clinicas de Porto Alegre - HCPA

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

University of Alberta Hospital - Walter C. Mackenzie Health Sciences Centre

Edmonton, Alberta, Canada

Site Status

University of Alberta - Zeidler Ledcor Centre

Edmonton, Alberta, Canada

Site Status

McMaster University Medical Center

Hamilton, Ontario, Canada

Site Status

London Health Sciences Centre - University Hospital

London, Ontario, Canada

Site Status

Montreal General Hospital - McGill University Health Centre

Montreal, Quebec, Canada

Site Status

Saskatoon City Hospital

Saskatoon, Saskatchewan, Canada

Site Status

Royal University Hospital

Saskatoon, Saskatchewan, Canada

Site Status

Instituto de Coloproctología ICO S.A.S.

Medellín, Antioquia, Colombia

Site Status

University Hospital Center Zagreb

Zagreb, , Croatia

Site Status

Hepato-Gastroenterologie HK, s.r.o.

Hradec Králové, , Czechia

Site Status

Nemocnice Strakonice, a.s., Interni oddeleni

Strakonice, , Czechia

Site Status

Krajska zdravotni, a.s. Masarykova nemocnice v Usti nad Labem

Ústí nad Labem, , Czechia

Site Status

Aalborg Hospital

Aalborg, , Denmark

Site Status

Aarhus University Hospital

Aarhus C, , Denmark

Site Status

Bispebjerg Hospital

Copenhagen NV, , Denmark

Site Status

Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Odense University Hospital

Odense C, , Denmark

Site Status

ECG Unit of West Tallinn Central Hospital

Tallinn, Estonia, Estonia

Site Status

West Tallinn Central Hospital

Tallinn, Estonia, Estonia

Site Status

X- Ray Department of West Tallinn Central Hospital

Tallinn, Estonia, Estonia

Site Status

X-Ray Unit, East Tallinn Central Hospital

Tallinn, , Estonia

Site Status

ECG Unit, Innomedica OU and Qualitas AS (ECG Only)

Tallinn, , Estonia

Site Status

Innomedica OU

Tallinn, , Estonia

Site Status

East Tallinn Central Hospital Internal Medical Clinic

Tallinn, , Estonia

Site Status

ECG Unit, East Tallinn Central Hospital

Tallinn, , Estonia

Site Status

X-Ray Department of West Tallinn Central Hospital

Tallinn, , Estonia

Site Status

Mammograaf OU (Endoscopy Only)

Tallinn, , Estonia

Site Status

CHU Amiens PICARDIE - Hopital SUD

Amiens, , France

Site Status

Hopital Saint Andre

Bordeaux, , France

Site Status

Hopital Beaujon

Clichy, , France

Site Status

Hotel-Dieu CHU Nantes

Nantes, , France

Site Status

Hopital Saint Louis - Service d'hepato-gastoenterologie

Paris, , France

Site Status

Hopital Saint Louis

Paris, , France

Site Status

Hopital Saint Antoine - Service de Gastroenterologie

Paris, , France

Site Status

C.H.U. de Reims - Hôpital Robert Debré

Reims, , France

Site Status

Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

Universitaetsklinikum Schleswig-Holstein, Campus Kiel

Kiel, Schlewig Holstein, Germany

Site Status

Universitaetsmedizin Berlin, Charite Campus Virchow-Klinikum,

Berlin, , Germany

Site Status

Universitätsklinikum Halle

Halle, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Klinikum Lüneburg/Abteilung Gastroenterologie

Lüneburg, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Minden

Minden, , Germany

Site Status

Universitaetsklinikum Ulm

Ulm, , Germany

Site Status

Dr Rethy Pal Korhaz-Rendelointezet, III Belgyogyaszat

Békéscsaba, Hungary, Hungary

Site Status

Szent Margit Korhaz - III Belgyogyaszat

Budapest, , Hungary

Site Status

Peterfy Sandor Utcai Korhaz Rendelointezet es Baleseti Kozpont

Budapest, , Hungary

Site Status

Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak

Budapest, , Hungary

Site Status

Pannonia Maganorvosi Centrum Kft.

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Intezet Gasztroenterologiai Tanszek

Debrecen, , Hungary

Site Status

Bekes Megyei Pandy Kalman Korhaz III. Gasztroenterologiai Osztaly

Gyula, , Hungary

Site Status

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz

Miskolc, , Hungary

Site Status

Karolina Korhaz

Mosonmagyaróvár, , Hungary

Site Status

Pecsi Tudomanyegyetem Klinikai Kozpont

Pécs, , Hungary

Site Status

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, I. Sz. Belgyogyaszati Klinika

Szeged, , Hungary

Site Status

Javorszky Odon Korhaz

Vác, , Hungary

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Rabin Medical Center, Beilinson campus

Petah Tikva, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

Istituto Clinico Humanitas IRCSS

Rozzano, Milano, Italy

Site Status

AOR Villa Sofia-Cervello

Palermo, PA, Italy

Site Status

AOU Mater Domini - U.O. Fisiopatologia Digestiva

Catanzaro, , Italy

Site Status

Aichi Medical University Hospital

Nagakute, Aichi-ken, Japan

Site Status

Hiroshima University Hospital

Hiroshima, Hiroshima, Japan

Site Status

Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

Sapporo, Hokkaido, Japan

Site Status

The Hospital of Hyogo College of Medicine

Nishinomiya, Hyōgo, Japan

Site Status

National Hospital Organization Mito Medical Center

Higashi-ibaraki-gun, Ibaraki, Japan

Site Status

Sameshima Hospital

Kagoshima, Kagoshima-ken, Japan

Site Status

Kuniyoshi Hospital

Kochi, Kochi, Japan

Site Status

National Hospital Organization Sendai Medical Center

Sendai, Miyagi, Japan

Site Status

Osaka City University Hospital

Osaka, Osaka, Japan

Site Status

Osaka Medical College Hospital

Takatsuki-shi, Osaka, Japan

Site Status

Shiga University of Medical Science Hospital

Ōtsu, Shiga, Japan

Site Status

Tokyo Medical And Dental University Hospital, Faculty of Medicine

Bunkyo-ku, Tokyo, Japan

Site Status

Tokai University Hachioji Hospital

Hachiōji, Tokyo, Japan

Site Status

Kitasato University Kitasato Institute Hospital

Minato-ku, Tokyo, Japan

Site Status

NTT Medical Center Tokyo

Shinagawa-ku, Tokyo, Japan

Site Status

Showa University Hospital

Shinagawa-ku, Tokyo, Japan

Site Status

Keio University Hospital

Shinjuku-ku, Tokyo, Japan

Site Status

Chiba University Hospital

Chiba, , Japan

Site Status

Toho University Sakura Medical Center

Chiba, , Japan

Site Status

Kurume University Hospital

Fukuoka, , Japan

Site Status

ECG room Clinic Linezers (ECG only) Riga East University Hospital

Riga, , Latvia

Site Status

X-Ray Department, Clinic Linezers (radiology only)

Riga, , Latvia

Site Status

Digestive Diseases Center GASTRO

Riga, , Latvia

Site Status

VU University Medical Center (VUMC)

Amsterdam, , Netherlands

Site Status

Academic Medical Centre

Amsterdam, , Netherlands

Site Status

University Medical Center Groningen (UMCG)

Groningen, , Netherlands

Site Status

Leiden University Medical Center (LUMC)

Leiden, , Netherlands

Site Status

Shakespeare Specialist Group

Milford, Auckland, New Zealand

Site Status

Tauranga Hospital

Tauranga, Bay of Plenty, New Zealand

Site Status

Christchurch Hospital

Christchurch, Canterbury, New Zealand

Site Status

Auckland City Hospital

Auckland, , New Zealand

Site Status

Southern District Health Board

Dunedin, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

P3 Research Limited

Wellington, , New Zealand

Site Status

Pacific Radiology (X-rays only)

Wellington, , New Zealand

Site Status

Bowen Hospital

Wellington, , New Zealand

Site Status

Centrum Medyczne Szpital Sw. Rodziny Sp. z o. o.

Lodz, Iodzkie, Poland

Site Status

Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych, Szpital Uniwersytecki nr 2 im

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Klinika Chorob Wewnetrznych i Gastroenterologii z

Warsaw, Masovian Voivodeship, Poland

Site Status

H-T. Centrum Medyczne - ENDOTERAPIA

Tychy, Silesian Voivodeship, Poland

Site Status

Gabinet Lekarski - Janusz Rudzinski

Bydgoszcz, , Poland

Site Status

Gabinet Endoskopii Przewodu Pokarmowego

Krakow, , Poland

Site Status

Oddzial Kliniczny Gastroenterologii Ogólnej i Onkologicznej, Uniwersytecki Szpital

Lodz, , Poland

Site Status

Endoskopia Sp. Z O.O.

Sopot, , Poland

Site Status

Nzoz Vivamed

Warsaw, , Poland

Site Status

Lexmedica

Wroclaw, , Poland

Site Status

Cabinet Particular Policlinic Algomed Srl

Timișoara, Timiș County, Romania

Site Status

Spitalul Universitar de Urgenta Bucharest

Bucharest, , Romania

Site Status

Municipal Institution of Healthcare City Clinical Hospital 12,

Saratov, Russia, Russia

Site Status

Federal state budget institution "State scientific centre of coloproctology"

Moscow, , Russia

Site Status

State Budget Institution of Healthcare Nizhniy Novgorod Regional Clinical Hospital named after N. A.

Nizhny Novgorod, , Russia

Site Status

Federal state Institution "Sibirian regional Medical centre of Federal Medicobiologic Agency",

Novosibirsk, , Russia

Site Status

Municipal Budget Institution of Healthcare of Novosibirsk " City Clinical Hospital No 12"

Novosibirsk, , Russia

Site Status

State Budget Educational Institution of Higher Professional Education

Novosibirsk, , Russia

Site Status

Federal State Budgetary Institution "Scientific Research Institute of Physiology and Fundamental

Novosibirsk, , Russia

Site Status

Non-State Healthcare Institution "Road Clinical Hospital at the station Samara"

Samara, , Russia

Site Status

Limited Liability Company Medical Company "Hepatolog"

Samara, , Russia

Site Status

Limited Liability Company Medical Company "Hepatolog"

Samara, , Russia

Site Status

Samara Diagnostic center, X-ray Department

Samara, , Russia

Site Status

State budget institution of healthcare of Yaroslavl region Regional clinical hospital

Yaroslavl, , Russia

Site Status

Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology

Belgrade, Serbia, Europe, Serbia

Site Status

Clinical Hospital Centre Zvezdara

Belgrade, , Serbia

Site Status

Military Medical Academy Belgrade

Belgrade, , Serbia

Site Status

Clinical Centre of Kragujevac

Kragujevac, , Serbia

Site Status

Clinical Centre of Vojvodina, Clinic for Gastroenterology and Hepatology

Novi Sad, , Serbia

Site Status

Clinical Centre of Vojvodina, Emergency Internal Medicine Division

Novi Sad, , Serbia

Site Status

"General Hospital ""Djordje Joanovic""

Zrenjanin, , Serbia

Site Status

Medak s.r.o.

Bratislava, , Slovakia

Site Status

KM Management spol. s.r.o.

Nitra, , Slovakia

Site Status

Aura SA, s.r.o.

Nové Mesto nad Váhom, , Slovakia

Site Status

Gastro I., s.r.o.

Prešov, , Slovakia

Site Status

Dr John Philip Wright

Claremont, Cape Town, South Africa

Site Status

Chris Hani Baragwanath Academic Hospital

Johannesburg, Gauteng, South Africa

Site Status

Panorama MediClinic

Cape Town, Western Cape, South Africa

Site Status

Louis Leipoldt Medical Centre

Cape Town, Western Cape, South Africa

Site Status

Endocare Research Centre

Western Cape, , South Africa

Site Status

Hanyang University Guri Hospital

Guri-si, Gyeonggi-do, South Korea

Site Status

KyungHee University Hospital

Seoul, Republic of Korea, South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Seoul National University Hospital,

Seoul, , South Korea

Site Status

Hospital Universitari de Bellvitge, Servicio de Digestivo

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Hospital Clinic i Provincial de Barcelona

Barcelona, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario de Fuenlabrada

Madrid, , Spain

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Internal Medicine Center of Crimean Republic Institution"Clinical Territorial Medical Community"

Simferopol, Ar Krym, Ukraine

Site Status

Municipal Healthcare Institution Kharkiv City Clinical Hospital #2, Proctology Department

Kharkiv, Ukraine, Ukraine

Site Status

SI "Railway Hospital of the SI "Odesa Railway"", Polyclinic Department,

Odesa, Ukraine, Ukraine

Site Status

Regional Municipal Institution "Chernivtsi Regional Clinical Hospital"

Chernivtsi, , Ukraine

Site Status

Regional Municipal Institution Chernivtsi Regional Clinical Hospital,

Chernivtsi, , Ukraine

Site Status

State Institution "Institute of Gastroenterology of the National Academy of Medical Sciences of

Dniepropetrovsk, , Ukraine

Site Status

State Institution "National L.T. Malaya Therapy Institute of National Academy of

Kharkiv, , Ukraine

Site Status

Kyiv Municipal Clinical Hospital #18, Proctology Department

Kyiv, , Ukraine

Site Status

LTD "St. Paraskeva Medical Center"

Lviv, , Ukraine

Site Status

Municipal City Clinical Hospital of the Emergency Medical Care, 1-st Therapy Department of hospital,

Lviv, , Ukraine

Site Status

Municipal Institution "Odesa Regional Clinical Hospital"

Odesa, , Ukraine

Site Status

SI "District Clin. Hosp.of Uzhgorod station (STSA "Lviv Railway", Therapy Dep., SBHEI "Uzhgorod Nat.

Uzhhorod, , Ukraine

Site Status

Vinnytsia Regional Clinical Hospital for Invalids of the Great Patriotic War, Therapy Department #2,

Vinnytsia, , Ukraine

Site Status

Motor-Sich clinic, LLC

Zaporizhzhia, , Ukraine

Site Status

Minicipal Institution City Hospital 7, Therapevtic Department,

Zaporizhzhia, , Ukraine

Site Status

Municipal Institution "City Hospital #7", Zaporizhzhia State Medical University

Zaporizhzhia, , Ukraine

Site Status

Addenbrooke's Hospital-Cambridge University Hospitals NHS Foundation Trust

Cambridge, Cambridgeshire, United Kingdom

Site Status

Department of Gastroenterology, Old Building

Bristol, England, United Kingdom

Site Status

University College Hospital

London, Greater London, United Kingdom

Site Status

NWLH NHS trust

Harrow, Middlesex, United Kingdom

Site Status

The North West London Hospitals NHS Trust

Harrow, Middlesex, United Kingdom

Site Status

Norfolk and Norwich University Hospital

Norwich, Norfolk, United Kingdom

Site Status

Addenbrooke's Hospital

Cambridge, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Brazil Canada Colombia Croatia Czechia Denmark Estonia France Germany Hungary Israel Italy Japan Latvia Netherlands New Zealand Poland Romania Russia Serbia Slovakia South Africa South Korea Spain Taiwan Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Panes J, D'Haens GR, Sands BE, Ng SC, Lawendy N, Kulisek N, Guo X, Wu J, Vranic I, Panaccione R, Vermeire S. Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European Gastroenterol J. 2024 Jul;12(6):793-801. doi: 10.1002/ueg2.12584. Epub 2024 May 22.

Reference Type DERIVED
PMID: 38778549 (View on PubMed)

Rubin DT, Torres J, Regueiro M, Reinisch W, Prideaux L, Kotze PG, Tan FH, Gardiner S, Mundayat R, Cadatal MJ, Ng SC. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohns Colitis 360. 2024 Jan 20;6(1):otae004. doi: 10.1093/crocol/otae004. eCollection 2024 Jan.

Reference Type DERIVED
PMID: 38425446 (View on PubMed)

Rubin DT, Salese L, Cohen M, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD. Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program. Therap Adv Gastroenterol. 2023 Aug 7;16:17562848231189122. doi: 10.1177/17562848231189122. eCollection 2023.

Reference Type DERIVED
PMID: 37560161 (View on PubMed)

Schreiber S, Rubin DT, Ng SC, Peyrin-Biroulet L, Danese S, Modesto I, Guo X, Su C, Kwok KK, Jo H, Chen Y, Yndestad A, Reinisch W, Dubinsky MC. Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24;17(11):1761-1770. doi: 10.1093/ecco-jcc/jjad104.

Reference Type DERIVED
PMID: 37402275 (View on PubMed)

Kristensen LE, Danese S, Yndestad A, Wang C, Nagy E, Modesto I, Rivas J, Benda B. Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance. Ann Rheum Dis. 2023 Jul;82(7):901-910. doi: 10.1136/ard-2022-223715. Epub 2023 Mar 17.

Reference Type DERIVED
PMID: 36931693 (View on PubMed)

Lee SD, Allegretti JR, Steinwurz F, Connelly SB, Lawendy N, Paulissen J, Gecse KB. Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore. BMC Gastroenterol. 2023 Feb 8;23(1):34. doi: 10.1186/s12876-022-02508-2.

Reference Type DERIVED
PMID: 36755231 (View on PubMed)

Winthrop KL, Yndestad A, Henrohn D, Danese S, Marsal S, Galindo M, Woolcott JC, Jo H, Kwok K, Shapiro AB, Jones TV, Diehl A, Su C, Panes J, Cohen SB. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatol Ther. 2023 Apr;10(2):357-373. doi: 10.1007/s40744-022-00507-z. Epub 2022 Dec 17.

Reference Type DERIVED
PMID: 36526796 (View on PubMed)

Sandborn WJ, Sands BE, Vermeire S, Leung Y, Guo X, Modesto I, Su C, Wang W, Panes J. Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program. Therap Adv Gastroenterol. 2022 Dec 5;15:17562848221136331. doi: 10.1177/17562848221136331. eCollection 2022.

Reference Type DERIVED
PMID: 36506749 (View on PubMed)

Lichtenstein GR, Bressler B, Francisconi C, Vermeire S, Lawendy N, Salese L, Sawyerr G, Shi H, Su C, Judd DT, Jones T, Loftus EV. Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2023 Jan 5;29(1):27-41. doi: 10.1093/ibd/izac084.

Reference Type DERIVED
PMID: 36342120 (View on PubMed)

Hudesman DP, Torres J, Salese L, Woolcott JC, Mundayat R, Su C, Mosli MH, Allegretti JR. Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program. Patient. 2023 Mar;16(2):95-103. doi: 10.1007/s40271-022-00603-w. Epub 2022 Nov 7.

Reference Type DERIVED
PMID: 36336750 (View on PubMed)

Targownik L, Dubinsky MC, Steinwurz F, Bushmakin AG, Cappelleri JC, Tai E, Gardiner S, Hur P, Panes J. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain. J Crohns Colitis. 2023 Apr 19;17(4):513-523. doi: 10.1093/ecco-jcc/jjac161.

Reference Type DERIVED
PMID: 36271912 (View on PubMed)

Sandborn WJ, D'Haens GR, Sands BE, Panaccione R, Ng SC, Lawendy N, Kulisek N, Modesto I, Guo X, Mundayat R, Su C, Vranic I, Panes J. Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme. J Crohns Colitis. 2023 Apr 3;17(3):338-351. doi: 10.1093/ecco-jcc/jjac141.

Reference Type DERIVED
PMID: 36124702 (View on PubMed)

Loftus EV, Baumgart DC, Gecse K, Kinnucan JA, Connelly SB, Salese L, Su C, Kwok KK, Woolcott JC, Armuzzi A. Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program. Inflamm Bowel Dis. 2023 May 2;29(5):744-751. doi: 10.1093/ibd/izac139.

Reference Type DERIVED
PMID: 35792493 (View on PubMed)

Winthrop KL, Vermeire S, Long MD, Panes J, Ng SC, Kulisek N, Mundayat R, Lawendy N, Vranic I, Modesto I, Su C, Melmed GY. Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2023 Jan 5;29(1):85-96. doi: 10.1093/ibd/izac063.

Reference Type DERIVED
PMID: 35648151 (View on PubMed)

Vavricka SR, Greuter T, Cohen BL, Reinisch W, Steinwurz F, Fellmann M, Guo X, Lawendy N, Paulissen J, Peyrin-Biroulet L. Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study. Therap Adv Gastroenterol. 2022 May 10;15:17562848221090834. doi: 10.1177/17562848221090834. eCollection 2022.

Reference Type DERIVED
PMID: 35574426 (View on PubMed)

Mukherjee A, Tsuchiwata S, Nicholas T, Cook JA, Modesto I, Su C, D'Haens GR, Sandborn WJ. Exposure-Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies. Clin Pharmacol Ther. 2022 Jul;112(1):90-100. doi: 10.1002/cpt.2601. Epub 2022 Apr 27.

Reference Type DERIVED
PMID: 35380740 (View on PubMed)

Feagan BG, Khanna R, Sandborn WJ, Vermeire S, Reinisch W, Su C, Salese L, Fan H, Paulissen J, Woodworth DA, Niezychowski W, Sands BE. Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials. Aliment Pharmacol Ther. 2021 Dec;54(11-12):1442-1453. doi: 10.1111/apt.16626. Epub 2021 Oct 6.

Reference Type DERIVED
PMID: 34614208 (View on PubMed)

Farraye FA, Qazi T, Kotze PG, Moore GT, Mundayat R, Lawendy N, Sharma PP, Judd DT. The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme. Aliment Pharmacol Ther. 2021 Aug;54(4):429-440. doi: 10.1111/apt.16439. Epub 2021 Jun 24.

Reference Type DERIVED
PMID: 34165201 (View on PubMed)

Rubin DT, Reinisch W, Greuter T, Kotze PG, Pinheiro M, Mundayat R, Maller E, Fellmann M, Lawendy N, Modesto I, Vavricka SR, Lichtenstein GR. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therap Adv Gastroenterol. 2021 May 16;14:17562848211005708. doi: 10.1177/17562848211005708. eCollection 2021.

Reference Type DERIVED
PMID: 34035832 (View on PubMed)

Panes J, Vermeire S, Dubinsky MC, Loftus EV, Lawendy N, Wang W, Salese L, Su C, Modesto I, Guo X, Colombel JF. Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials. J Crohns Colitis. 2021 Nov 8;15(11):1852-1863. doi: 10.1093/ecco-jcc/jjab065.

Reference Type DERIVED
PMID: 33884415 (View on PubMed)

Sandborn WJ, Peyrin-Biroulet L, Sharara AI, Su C, Modesto I, Mundayat R, Gunay LM, Salese L, Sands BE. Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status. Clin Gastroenterol Hepatol. 2022 Mar;20(3):591-601.e8. doi: 10.1016/j.cgh.2021.02.043. Epub 2021 Mar 6.

Reference Type DERIVED
PMID: 33684552 (View on PubMed)

Vong C, Martin SW, Deng C, Xie R, Ito K, Su C, Sandborn WJ, Mukherjee A. Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis. Clin Pharmacol Drug Dev. 2021 Mar;10(3):229-240. doi: 10.1002/cpdd.899. Epub 2021 Jan 29.

Reference Type DERIVED
PMID: 33513294 (View on PubMed)

Curtis JR, Regueiro M, Yun H, Su C, DiBonaventura M, Lawendy N, Nduaka CI, Koram N, Cappelleri JC, Chan G, Modesto I, Lichtenstein GR. Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data. Inflamm Bowel Dis. 2021 Aug 19;27(9):1394-1408. doi: 10.1093/ibd/izaa289.

Reference Type DERIVED
PMID: 33324993 (View on PubMed)

Colombel JF, Osterman MT, Thorpe AJ, Salese L, Nduaka CI, Zhang H, Lawendy N, Friedman GS, Quirk D, Su C, Reinisch W. Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 Jan;20(1):116-125.e5. doi: 10.1016/j.cgh.2020.10.004. Epub 2020 Oct 9.

Reference Type DERIVED
PMID: 33039585 (View on PubMed)

Sands BE, Colombel JF, Ha C, Farnier M, Armuzzi A, Quirk D, Friedman GS, Kwok K, Salese L, Su C, Taub PR. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflamm Bowel Dis. 2021 May 17;27(6):797-808. doi: 10.1093/ibd/izaa227.

Reference Type DERIVED
PMID: 32870265 (View on PubMed)

Panaccione R, Isaacs JD, Chen LA, Wang W, Marren A, Kwok K, Wang L, Chan G, Su C. Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials. Dig Dis Sci. 2021 Aug;66(8):2732-2743. doi: 10.1007/s10620-020-06560-4. Epub 2020 Aug 20.

Reference Type DERIVED
PMID: 32816215 (View on PubMed)

Lichtenstein GR, Rogler G, Ciorba MA, Su C, Chan G, Pedersen RD, Lawendy N, Quirk D, Nduaka CI, Thorpe AJ, Panes J. Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2021 May 17;27(6):816-825. doi: 10.1093/ibd/izaa199.

Reference Type DERIVED
PMID: 32766762 (View on PubMed)

Sandborn WJ, Panes J, Sands BE, Reinisch W, Su C, Lawendy N, Koram N, Fan H, Jones TV, Modesto I, Quirk D, Danese S. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Aliment Pharmacol Ther. 2019 Nov;50(10):1068-1076. doi: 10.1111/apt.15514. Epub 2019 Oct 9.

Reference Type DERIVED
PMID: 31599001 (View on PubMed)

Sands BE, Taub PR, Armuzzi A, Friedman GS, Moscariello M, Lawendy N, Pedersen RD, Chan G, Nduaka CI, Quirk D, Salese L, Su C, Feagan BG. Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Jan;18(1):123-132.e3. doi: 10.1016/j.cgh.2019.04.059. Epub 2019 May 8.

Reference Type DERIVED
PMID: 31077827 (View on PubMed)

Sandborn WJ, Panes J, D'Haens GR, Sands BE, Su C, Moscariello M, Jones T, Pedersen R, Friedman GS, Lawendy N, Chan G. Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1541-1550. doi: 10.1016/j.cgh.2018.11.035. Epub 2018 Nov 23.

Reference Type DERIVED
PMID: 30476584 (View on PubMed)

Winthrop KL, Melmed GY, Vermeire S, Long MD, Chan G, Pedersen RD, Lawendy N, Thorpe AJ, Nduaka CI, Su C. Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

Reference Type DERIVED
PMID: 29850873 (View on PubMed)

Motoya S, Watanabe M, Kim HJ, Kim YH, Han DS, Yuasa H, Tabira J, Isogawa N, Arai S, Kawaguchi I, Hibi T. Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies. Intest Res. 2018 Apr;16(2):233-245. doi: 10.5217/ir.2018.16.2.233. Epub 2018 Apr 30.

Reference Type DERIVED
PMID: 29743836 (View on PubMed)

Panes J, Vermeire S, Lindsay JO, Sands BE, Su C, Friedman G, Zhang H, Yarlas A, Bayliss M, Maher S, Cappelleri JC, Bushmakin AG, Rubin DT. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis. 2018 Jan 24;12(2):145-156. doi: 10.1093/ecco-jcc/jjx133.

Reference Type DERIVED
PMID: 29028981 (View on PubMed)

Sandborn WJ, Su C, Sands BE, D'Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panes J; OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910.

Reference Type DERIVED
PMID: 28467869 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-004580-79

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

OCTAVESUSTAIN

Identifier Type: OTHER

Identifier Source: secondary_id

A3921096

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP101 for the Treatment of Ulcerative Colitis
NCT05852574 ACTIVE_NOT_RECRUITING PHASE1